Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyumjev versus Humalog in the Inreda bihormonal artificial pancreas for type 1 diabetes
NL-OMON51782Active, not recruiting
- Sponsor
- Inreda Diabetic
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin lispro and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Inreda Diabetic. Primary endpoint: Time above range. Started Oct 2022; status: active, not recruiting.
02
Drugs
insulin lisprohuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON51782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51782.